Pharmacy Grand Rounds
Breaking the Bank: Financial Toxicity in Oncology

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)

Until future notice, learners must watch Pharmacy Grand Rounds live via the web by going to the Video Exchange and selecting “Pharmacy Grand Rounds” in the “Streaming Now” section.

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

There have been incredible advances in oncology care over the past several decades, but these advances are matched with increased cost of therapy. Cancer is the second most expensive disease in the U.S. with an estimated health care cost of $157 billion in 2020. Approximately 5% of the U.S. population are cancer survivors that have to manage this financial burden. Financial toxicity describes both the direct and indirect health care costs that affect patients and caregivers. During this presentation, we will review the background of financial toxicity, its impacts on clinical outcomes, and proposed methods to address this issue with patients.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Review the definition, background, and measurement of financial toxicity
2. Discuss the impact of financial toxicity on patients’ clinical outcomes
3. Identify methods to help patients make informed decisions about their oncology care

Session Announcement

Session Slides

FACULTY INFORMATION

Allison P. Golbach, PharmD
PGY2 Oncology Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Allison received a Doctor of Pharmacy degree from Drake University and subsequently completed a PGY1 Pharmacy Residency at Mayo Clinic Hospital – Rochester. She is a current PGY2 Oncology Pharmacy Resident at Mayo Clinic Hospital-Rochester with practice interests in hematology, oncology, and pharmacogenomics.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Allison P. Golbach PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will not be discussed during this presentation.

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS